Commentary on "Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study"
Int J Impot Res. 2024 Apr;36(2):166-167.
doi: 10.1038/s41443-023-00811-4.
Epub 2023 Dec 18.
1 Unit of Urology, Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Naples, 80131, Italy. manfredi.celeste@gmail.com.
2 Department of Urology, Rush University Medical Center, 60612, Chicago, IL, USA. manfredi.celeste@gmail.com.
3 Department of Urology, Rush University Medical Center, 60612, Chicago, IL, USA.
4 Unit of Urology, Department of Maternal-Child and Urological Sciences, "Sapienza" University of Rome, Policlinico Umberto I Hospital, 00185, Rome, Italy.